NAF’s Ataxia Clinical Training (ACT) program debuted in March 2022. The primary objective of this training session is to acquire practical knowledge about the diagnostic investigation and treatment of the Ataxias through a series of didactic talks by clinicians who have significant experience in this area. Attendees are introduced to ongoing research in the field of Ataxia and have the ability to personally interact with patients and families affected by a wide-spectrum of Ataxic disorders. The ACT includes topics on diagnostic approach to Ataxias, heredodegenerative and Acquired Ataxias, neurogenetics of Ataxias, treatment of Ataxia, and research on Ataxia.

ACT provides Fellows with the ability to interact with Ataxia experts, many of whom are reputable clinicians and scientists, and explore opportunities for specializing in this field. There is a need for new talent and ideas, given we are ushering in an era of cutting-edge molecular, biopharmaceutical and bioengineering tools which hold significant promise for the cure of neurodegenerative disorders. The highlight of ACT is interactions between fellows and patients affected by a wide-spectrum of Ataxic disorders. Very few conferences offer the opportunity to bolster didactic knowledge with clinical experience making this course unique in its training scope.

ACT will take place on March 30 – April 1, 2023.